TY - JOUR
T1 - The impact of tralokinumab on quality of life and school in patients aged 12鈥�17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial
JO - SKIN The Journal of Cutaneous Medicine
UR - http://dx.doi.org/10.25251/skin.6.supp.77
PY - 2022/11/16
AU - Paller AS
AU - Silverberg JI
AU - Hong C-H
AU - Cork M
AU - Puig L
AU - Arlert P
AU - Kurbasic A
AU - Soldbro L
AU - Simpson EL
ED -
DO - DOI: 10.25251/skin.6.supp.77
PB - National Society for Cutaneous Medicine
VL - 6
IS - 6
SP - s77
EP - s77
Y2 - 2025/07/17
ER -